Molecular, Histological, and Clinical Effects of Selective TYK2 Inhibition with Zasocitinib (TAK-279) in Patients with Moderate-to-Severe Plaque Psoriasis

Journal of Investigative Dermatology, 2025

Choudhury A., Garcet S., Cueto I., Kunjravia N., Li X., Rambhia D., Kumar S., Arunachalam V., Blau J., Cheng J., Hong F., Saha B., Tang J., Zhang W., Wennbo H., Thakker P., Krueger J.